Industry Trends

A new analysis shows that structural forces — not patient need — shape who gets primary care.

Factors across U.S. health care pose a ‘dire threat’ to ‘severely destabilized’ independent private practice, threatening patient access.

Appointment wait times are growing, according to new data from AMN Healthcare.

While attention on physician wellness from a television show is welcome, these doctors have been working on the issue for years. Hear their story

As digital clinics race to capitalize on the GLP-1 weight loss boom, concerns grow over quality, safety and the erosion of patient-centered care.

Caroline Pearson, executive director of the Peterson Center on Healthcare, explains a new analysis of use and payment for remote monitoring technologies.

Caroline Pearson, executive director of the Peterson Center on Healthcare, explains a new analysis of use and payment for remote monitoring technologies.

Caroline Pearson, executive director of the Peterson Center on Healthcare, explains a new analysis of use and payment for remote monitoring technologies.

Caroline Pearson, executive director of the Peterson Center on Healthcare, explains a new analysis of use and payment for remote monitoring technologies.

Caroline Pearson, executive director of the Peterson Center on Healthcare, explains a new analysis of use and payment for remote monitoring technologies.

Caroline Pearson, executive director of the Peterson Center on Healthcare, explains a new analysis of use and payment for remote monitoring technologies.

A ScienceSoft report finds technology and demand are in place, but regulatory uncertainty looms.

HHS announces plan to create ‘most-favored-nation’ cost scale so U.S. is not subsidizing drug prices in other countries.

APC CEO Scott Brunner, CAE, discusses compounding drugs, including the GLP-1 RA antidiabetes and antiobesity medications.

APC CEO Scott Brunner, CAE, discusses compounding drugs, including the GLP-1 RA antidiabetes and antiobesity medications.

APC CEO Scott Brunner, CAE, discusses compounding drugs, including the GLP-1 RA antidiabetes and antiobesity medications.

APC CEO Scott Brunner, CAE, discusses compounding drugs, including the GLP-1 RA antidiabetes and antiobesity medications.

APC CEO Scott Brunner, CAE, discusses compounding drugs, including the GLP-1 RA antidiabetes and antiobesity medications.

APC CEO Scott Brunner, CAE, discusses compounding drugs, including the GLP-1 RA antidiabetes and antiobesity medications.

APC CEO Scott Brunner, CAE, discusses compounding drugs, including the GLP-1 RA antidiabetes and antiobesity medications.

Trump administration tallies ‘staggering cost’ of opioid epidemic as lawmakers ponder budget.

As use of artificial intelligence grows rapidly in health care, the American Medical Association brought together an expert panel to highlight policy changes, transparency concerns and implications for physician practices.

Ultraprocessed foods, oil-based dyes are FDA targets as part of Make America Healthy Again initiative.

Public health communicator and digital strategist to lead the American Medical Association — the nation’s largest physician group.

National Comprehensive Cancer Network holds policy summit on collaboration in oncology, primary care.